zirconium has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boros, E; Caravan, P; Carlson, JC; Meimetis, LG; Ran, C; Weissleder, R | 1 |
Kanie, O; Kanie, Y; Taniuchi, M | 1 |
2 other study(ies) available for zirconium and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
Article | Year |
---|---|
Bioorthogonal Fluorophore Linked DFO-Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies.
Topics: Animals; Antibodies, Monoclonal; Boron Compounds; Chelating Agents; Deferoxamine; Female; Fluorescent Dyes; Humans; Mice, Nude; Multimodal Imaging; Positron-Emission Tomography; Radioisotopes; Receptor, ErbB-2; Tissue Distribution; Trastuzumab; Xenograft Model Antitumor Assays; Zirconium | 2016 |
Evaluation of reversed-phase nano liquid chromatography conditions by using reversed-phase thin layer chromatography based on Hansen solubility parameters for the analysis of amphiphilic glycosylsphingolipid transformations.
Topics: Animals; Boron Compounds; CHO Cells; Chromatography, Reverse-Phase; Chromatography, Thin Layer; Cricetinae; Cricetulus; Hydrogen Bonding; Nanotechnology; Psychosine; Silicon Dioxide; Solubility; Solvents; Sphingolipids; Zirconium | 2018 |